Astrazeneca Dividends - AZN

Astrazeneca Dividends - AZN

[ADVERT]
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type
Astrazeneca Plc AZN London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
177.00 2.04% 8,845.00 16:35:14
Open Price Low Price High Price Close Price Previous Close
8,900.00 8,828.00 8,982.00 8,845.00 8,668.00
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Astrazeneca AZN Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
29/07/2021InterimUSX9031/12/202031/12/202112/08/202113/08/202113/09/20210
16/02/2021InterimUSX19031/12/201931/12/202025/02/202126/02/202129/03/2021280
30/07/2020InterimUSX9031/12/201931/12/202013/08/202014/08/202014/09/20200
14/02/2020InterimUSX19031/12/201831/12/201927/02/202028/02/202030/03/2020280
25/07/2019InterimUSX9031/12/201831/12/201908/08/201909/08/201909/09/20190
14/02/2019FinalUSX19031/12/201731/12/201828/02/201901/03/201927/03/2019280
26/07/2018InterimUSX9031/12/201731/12/201809/08/201810/08/201810/09/20180
02/02/2018FinalUSX19031/12/201631/12/201715/02/201816/02/201819/03/2018280
27/07/2017InterimUSX9031/12/201631/12/201710/08/201711/08/201711/09/20170
02/02/2017FinalUSX19031/12/201531/12/201616/02/201717/02/201720/03/2017280
28/07/2016InterimUSX9031/12/201531/12/201611/08/201612/08/201612/09/20160
04/02/2016FinalUSX19031/12/201431/12/201518/02/201619/02/201621/03/2016280
30/07/2015InterimUSX9031/12/201431/12/201513/08/201514/08/201514/09/20150
05/02/2015FinalUSX19031/12/201331/12/201419/02/201520/02/201523/03/2015280
31/07/2014InterimUSX9031/12/201331/12/201413/08/201415/08/201415/09/20140
06/02/2014FinalUSX19031/12/201231/12/201319/02/201421/02/201424/03/2014280
01/08/2013InterimUSX9031/12/201231/12/201314/08/201316/08/201316/09/20130
31/01/2013FinalUSX19031/12/201131/12/201213/02/201315/02/201318/03/2013280
26/07/2012InterimUSX9031/12/201131/12/201208/08/201210/08/201210/09/20120
02/02/2012FinalUSX19531/12/201031/12/201115/02/201217/02/201219/03/2012280
28/07/2011InterimUSX8531/12/201031/12/201103/08/201105/08/201112/09/20110
27/01/2011FinalUSX18531/12/200931/12/201002/02/201104/02/201114/03/2011255
29/07/2010InterimUSX7031/12/200931/12/201002/08/201004/08/201013/09/20100
28/01/2010FinalUSX17131/12/200831/12/200903/02/201005/02/201015/03/2010230
30/07/2009InterimUSX5930/12/200830/06/200905/08/200907/08/200914/09/20090
29/01/2009FinalUSX15031/12/200731/12/200804/02/200906/02/200916/03/2009205
31/07/2008InterimUSX5530/12/200730/06/200808/08/200806/08/200815/09/20080
31/01/2008FinalUSX13531/12/200631/12/200706/02/200808/02/200817/03/2008187
26/07/2007InterimUSX5230/06/200630/06/200708/08/200710/08/200717/09/20070
01/02/2007FinalUSX12331/12/200531/12/200607/02/200709/02/200719/03/2007172
27/07/2006InterimUSX4930/12/200530/06/200609/08/200611/08/200618/09/20060
01/02/2006FinalUSX9231/12/200431/12/200508/02/200610/02/200620/03/2006130
29/07/2005InterimUSX3830/12/200430/06/200510/08/200512/08/200519/09/20050
27/01/2005FinalUSX64.531/12/200331/12/200409/02/200511/02/200521/03/200594
22/07/2004InterimUSX29.530/12/200330/06/200411/08/200413/08/200420/09/20040
29/01/2004FinalUSX5431/12/200231/12/200318/02/200420/02/200406/04/200479.5
24/07/2003InterimUSX25.530/12/200230/06/200320/08/200322/08/200306/10/20030
30/01/2003FinalUSX4731/12/200131/12/200219/02/200321/02/200307/04/200370
25/07/2002InterimUSX2330/12/200130/06/200221/08/200223/08/200207/10/20020
31/01/2002FinalUSX4731/12/200031/12/200120/02/200222/02/200208/04/200270
26/07/2001InterimUSX2330/12/200030/06/200122/08/200124/08/200105/10/20010
08/02/2001FinalUSX4731/12/199931/12/200021/02/200123/02/200109/04/200170
01/08/2000InterimUSX2330/12/199930/06/200004/09/200008/09/200023/10/20000
24/02/2000FinalUSX4731/12/199831/12/199906/03/200010/03/200017/04/200070
03/08/1999InterimUSX2330/12/199830/06/199906/09/199910/09/199925/10/19990

Top Dividend Posts

DateSubject
21/9/2021
08:16
arja: seems to be holding AZN back today so far as I was expecting it to kick on a bit !
20/9/2021
16:15
hotfinance14: This should close over £5 up as it is masskve news for AZN.
20/9/2021
15:19
philanderer: AZN best one of my lot by a mile today.
19/9/2021
11:31
riskonricky: I admire your enthusiasm, but based on what? The whole her2 inhibitor market is $5-6Billion. AZN is a £125 billon company. How on earth would this news make it rocket? And where would it rocket to?
14/9/2021
12:42
umitw: I wonder why sajid decided to have Moderna & Pfizer as a bossier not AZN..?
10/9/2021
11:41
hjs: AZN has gone down as a result of their "Vaccine Booster" statement. Market will always react to any news to mark the share price up or down! this is my view.
03/9/2021
15:42
stutes: Today's deal with EU shows to me AZN sorted the mess out but the company itself needs to address the reasons why it messed up.
07/8/2021
09:22
gibbs1: August/12/2021 Ex-dividend day for interim dividend
01/8/2021
09:09
waldron: CAMBRIDGE, Britain (AP) _ Astrazeneca PLC (AZN) on Thursday reported second-quarter profit of $550 million. The Cambridge, Britain-based company said it had profit of 21 cents per share. Earnings, adjusted for non-recurring costs, came to 45 cents per share. The pharmaceutical posted revenue of $8.22 billion in the period. Astrazeneca shares have increased 14% since the beginning of the year. The stock has climbed almost 1% in the last 12 months. This story was generated by Automated Insights (Http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AZN at Https://www.zacks.com/ap/AZN
26/5/2021
09:49
beckers2008: N100, More like, AZN will confront and prove that the contract the EU signed was 'best efforts' as AZN were contractually committed to the UK. Now it has gone to court, AZN can show what a shambles the EU procurement process is. The EU will not come out of this in a good light, that is assured!
ADVFN Advertorial
Your Recent History
LSE
AZN
Astrazenec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210925 19:02:27